N-Acetylcysteine and Ceftriaxone as Preconditioning Strategies in Focal Brain Ischemia: Influence on Glutamate Transporters Expression

Neurotoxicity Research

Volumn 29, Issue 4, 2016, Pages 539-550

  Krzyzanowska, Weronika ^a   Pomierny, Bartosz ^a   Budziszewska, Boguslawa ^a   Filip, Malgorzata ^a   Pera, Joanna ^a  

^a JAGIELLONIAN UNIVERSITY   (Poland)

Author keywords

Brain ischemia; Brain preconditioning; Ceftriaxone; N acetylcysteine; Neuroprotection

Indexed keywords

3 NITROPROPIONIC ACID; ACETYLCYSTEINE; CEFTRIAXONE; GLUTAMATE TRANSPORTER; PROTEIN XC; UNCLASSIFIED DRUG; VESICULAR GLUTAMATE TRANSPORTER 1; EXCITATORY AMINO ACID TRANSPORTER 2; MESSENGER RNA; NEUROPROTECTIVE AGENT; SLC1A2 PROTEIN, RAT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BRAIN INFARCTION SIZE; BRAIN ISCHEMIA; CONTROLLED STUDY; CORPUS STRIATUM; DORSAL STRIATUM; FRONTAL CORTEX; GENE EXPRESSION; GLT 1 GENE; HIPPOCAMPUS; ISCHEMIC PRECONDITIONING; MALE; NEUROPROTECTION; NONHUMAN; PHYSICAL TOLERANCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; XC GENE; ANALYSIS OF VARIANCE; ANIMAL; BRAIN; BRAIN EDEMA; BRAIN INFARCTION; COMPLICATION; DISEASE MODEL; DRUG ADMINISTRATION; DRUG EFFECTS; ENZYME LINKED IMMUNOSORBENT ASSAY; GENE EXPRESSION REGULATION; GENETICS; INFARCTION, MIDDLE CEREBRAL ARTERY; METABOLISM; NERVOUS SYSTEM DISEASES; PATHOLOGY; WISTAR RAT;

ACETYLCYSTEINE; ANALYSIS OF VARIANCE; ANIMALS; BRAIN; BRAIN EDEMA; BRAIN INFARCTION; CEFTRIAXONE; DISEASE MODELS, ANIMAL; DRUG ADMINISTRATION SCHEDULE; ENZYME-LINKED IMMUNOSORBENT ASSAY; EXCITATORY AMINO ACID TRANSPORTER 2; GENE EXPRESSION REGULATION; INFARCTION, MIDDLE CEREBRAL ARTERY; MALE; NERVOUS SYSTEM DISEASES; NEUROPROTECTIVE AGENTS; RATS; RATS, WISTAR; RNA, MESSENGER;

EID: 84957667580     PISSN: 10298428     EISSN: 14763524     Source Type: Journal    
DOI: 10.1007/s12640-016-9602-z     Document Type: Article

References (43)

1. Bigdeli MR, Hajizadeh S, Froozandeh M, Heidarianpour A, Rasoulian B, Asgari AR, Pourkhalili K, Khoshbaten A (2008) Normobaric hyperoxia induces ischemic tolerance and upregulation of glutamate transporters in the rat brain and serum TNF-alpha level. Exp Neurol 212:298–306
2. Bigdeli MR, Rahnema M, Khoshbaten A (2009) Preconditioning with sublethal ischemia or intermittent normobaric hyperoxia up-regulates glutamate transporters and tumor necrosis factor-(alpha) converting enzyme in the rat brain. J Stroke Cerebrovasc Dis 18:336–342
3. Chu K, Lee ST, Sinn DI, Ko SY, Kim EH, Kim JM, Kim SJ, Park DK, Jung KH, Song EC, Lee SK, Kim M, Roh JK (2007) Pharmacological induction of ischemic tolerance by glutamate transporter-1 (EAAT2) upregulation. Stroke 38:177–182
4. Danbolt NC (2001) Glutamate uptake. Prog Neurobiol 65:1–105
5. Douen AG, Akiyama K, Hogan MJ, Wang F, Dong L, Chow AK, Hakim A (2000) Preconditioning with cortical spreading depression decreases intraischemic cerebral glutamate levels and down-regulates excitatory amino acid transporters EAAT1 and EAAT2 from rat cerebal cortex plasma membranes. J Neurochem 75:812–818
6. Fogal B, Li J, Lobner D, McCullough LD, Hewett SJ (2007) System x(c)- activity and astrocytes are necessary for interleukin-1 beta-mediated hypoxic neuronal injury. J Neurosci 27:10094–10105
7. Garcia JH, Liu KF, Ho KL (1995) Neuronal necrosis after middle cerebral artery occlusion in wistar rats progresses at different time intervals in the caudoputamen and the cortex. Stroke 26:636–642 discussion 643
8. Globus MY, Busto R, Martinez E, Valdes I, Dietrich WD, Ginsberg MD (1991) Comparative effect of transient global ischemia on extracellular levels of glutamate, glycine, and gamma-aminobutyric acid in vulnerable and nonvulnerable brain regions in the rat. J Neurochem 57:470–478
9. Justicia C, Gabriel C, Planas AM (2000) Activation of the JAK/STAT pathway following transient focal cerebral ischemia: Signaling through Jak1 and Stat3 in astrocytes. Glia 30:253–270
10. Ketheeswaranathan P, Turner NA, Spary EJ, Batten TF, McColl BW, Saha S (2011) Changes in glutamate transporter expression in mouse forebrain areas following focal ischemia. Brain Res 1418:93–103
11. Knackstedt LA, Melendez RI, Kalivas PW (2010) Ceftriaxone restores glutamate homeostasis and prevents relapse to cocaine seeking. Biol Psychiatry 67:81–84
12. Koizumi J, Yoshida Y, Nakazawa T, Ohneda G (1986) Experimental studies of ischemic brain edema. Part I: a new experimental model of cerebral embolism in rats in which recirculation can be introduced in the ischemic area. J Stroke 8:1–8
13. Kosugi T, Kawahara K, Yamada T, Nakajima T, Tanaka M (2005) Functional significance of the preconditioning-induced down-regulation of glutamate transporter GLT-1 in neuron/astrocyte co-cultures. Neurochem Res 30:1109–1116
14. Lai PC, Huang YT, Wu CC, Lai CJ, Wang PJ, Chiu TH (2011) Ceftriaxone attenuates hypoxic-ischemic brain injury in neonatal rats. J Biomed Sci 18:69-0127-18-69
15. Lee SG, Su ZZ, Emdad L, Gupta P, Sarkar D, Borjabad A, Volsky DJ, Fisher PB (2008) Mechanism of ceftriaxone induction of excitatory amino acid transporter-2 expression and glutamate uptake in primary human astrocytes. J Biol Chem 283:13116–13123
16. Lewerenz J, Albrecht P, Tien ML, Henke N, Karumbayaram S, Kornblum HI, Wiedau-Pazos M, Schubert D, Maher P, Methner A (2009) Induction of Nrf2 and xCT are involved in the action of the neuroprotective antibiotic ceftriaxone in vitro. J Neurochem 111:332–343
17. Lewerenz J, Hewett SJ, Huang Y, Lambros M, Gout PW, Kalivas PW, Massie A, Smolders I, Methner A, Pergande M, Smith SB, Ganapathy V, Maher P (2013) The cystine/glutamate antiporter system x(c)(-) in health and disease: from molecular mechanisms to novel therapeutic opportunities. Antioxid Redox Signal 18:522–555
18. Lipton P (1999) Ischemic cell death in brain neurons. Physiol Rev 79:1431–1568
19. Liu AJ, Hu YY, Li WB, Xu J, Zhang M (2011) Cerebral ischemic pre-conditioning enhances the binding characteristics and glutamate uptake of glial glutamate transporter-1 in hippocampal CA1 subfield of rats. J Neurochem 119:202–209
20. Massie A, Boillee S, Hewett S, Knackstedt L, Lewerenz J (2015) Main path and byways: non-vesicular glutamate release by system x as an important modifier of glutamatergic neurotransmission. J Neurochem. doi:10.1111/jnc.13348
21. Nair S, Doh ST, Chan JY, Kong AN, Cai L (2008) Regulatory potential for concerted modulation of Nrf2- and Nfkb1-mediated gene expression in inflammation and carcinogenesis. Br J Cancer 99:2070–2082
22. Nurmi A, Lindsberg PJ, Koistinaho M, Zhang W, Juettler E, Karjalainen-Lindsberg ML, Weih F, Frank N, Schwaninger M, Koistinaho J (2004) Nuclear factor-kappaB contributes to infarction after permanent focal ischemia. Stroke 35:987–991
23. Pera J, Zawadzka M, Kaminska B, Szczudlik A (2004) Influence of chemical and ischemic preconditioning on cytokine expression after focal brain ischemia. J Neurosci Res 78:132–140
24. Phillips JB, Williams AJ, Adams J, Elliott PJ, Tortella FC (2000) Proteasome inhibitor PS519 reduces infarction and attenuates leukocyte infiltration in a rat model of focal cerebral ischemia. Stroke 31:1686–1693
25. Piani D, Fontana A (1994) Involvement of the cystine transport system xc- in the macrophage-induced glutamate-dependent cytotoxicity to neurons. J Immunol 152:3578–3585
26. Pradillo JM, Hurtado O, Romera C, Cardenas A, Fernandez-Tome P, Alonso-Escolano D, Lorenzo P, Moro MA, Lizasoain I (2006) TNFR1 mediates increased neuronal membrane EAAT3 expression after in vivo cerebral ischemic preconditioning. Neuroscience 138:1171–1178
27. Raghavendra Rao VL, Rao AM, Dogan A, Bowen KK, Hatcher J, Rothstein JD, Dempsey RJ (2000) Glial glutamate transporter GLT-1 down-regulation precedes delayed neuronal death in gerbil hippocampus following transient global cerebral ischemia. Neurochem Int 36:531–537
28. Romera C, Hurtado O, Mallolas J, Pereira MP, Morales JR, Romera A, Serena J, Vivancos J, Nombela F, Lorenzo P, Lizasoain I, Moro MA (2007) Ischemic preconditioning reveals that GLT1/EAAT2 glutamate transporter is a novel PPARgamma target gene involved in neuroprotection. J Cereb Blood Flow Metab 27:1327–1338
29. Rothstein JD, Patel S, Regan MR, Haenggeli C, Huang YH, Bergles DE, Jin L, Dykes Hoberg M, Vidensky S, Chung DS, Toan SV, Bruijn LI, Su ZZ, Gupta P, Fisher PB (2005) Beta-lactam antibiotics offer neuroprotection by increasing glutamate transporter expression. Nature (England) 433:73–77
30. Sanchez-Mendoza E, Burguete MC, Castello-Ruiz M, Gonzalez MP, Roncero C, Salom JB, Arce C, Canadas S, Torregrosa G, Alborch E, Oset-Gasque MJ (2010) Transient focal cerebral ischemia significantly alters not only EAATs but also VGLUTs expression in rats: relevance of changes in reactive astroglia. J Neurochem 113:1343–1355
31. Sato H, Tamba M, Ishii T, Bannai S (1999) Cloning and expression of a plasma membrane cystine/glutamate exchange transporter composed of two distinct proteins. J Biol Chem 274:11455–11458
32. Schneider A, Martin-Villalba A, Weih F, Vogel J, Wirth T, Schwaninger M (1999) NF-kappaB is activated and promotes cell death in focal cerebral ischemia. Nat Med 5:554–559
33. Schreck R, Albermann K, Baeuerle PA (1992) Nuclear factor kappa B: an oxidative stress-responsive transcription factor of eukaryotic cells (a review). Free Radic Res Commun 17:221–237
34. Sekhon B, Sekhon C, Khan M, Patel SJ, Singh I, Singh AK (2003) N-acetyl cysteine protects against injury in a rat model of focal cerebral ischemia. Brain Res 971:1–8
35. Sims B, Clarke M, Francillion L, Kindred E, Hopkins ES, Sontheimer H (2012) Hypoxic preconditioning involves system xc- regulation in mouse neural stem cells. Stem Cell Res 8:285–291
36. Takahashi K, Kong Q, Lin Y, Stouffer N, Schulte DA, Lai L, Liu Q, Chang LC, Dominguez S, Xing X, Cuny GD, Hodgetts KJ, Glicksman MA, Lin CL (2015) Restored glial glutamate transporter EAAT2 function as a potential therapeutic approach for alzheimer’s disease. J Exp Med 212:319–332
37. Thiel A, Heiss WD (2011) Imaging of microglia activation in stroke. Stroke 42:507–512
38. Thompson JW, Narayanan SV, Perez-Pinzon MA (2012) Redox signaling pathways involved in neuronal ischemic preconditioning. Curr Neuropharmacol 10:354–369
39. Thone-Reineke C, Neumann C, Namsolleck P, Schmerbach K, Krikov M, Schefe JH, Lucht K, Hortnagl H, Godes M, Muller S, Rumschussel K, Funke-Kaiser H, Villringer A, Steckelings UM, Unger T (2008) The beta-lactam antibiotic, ceftriaxone, dramatically improves survival, increases glutamate uptake and induces neurotrophins in stroke. J Hypertens 26:2426–2435
40. Verma R, Mishra V, Sasmal D, Raghubir R (2010) Pharmacological evaluation of glutamate transporter 1 (GLT-1) mediated neuroprotection following cerebral ischemia/reperfusion injury. Eur J Pharmacol 638:65–71
41. Wiegand F, Liao W, Busch C, Castell S, Knapp F, Lindauer U, Megow D, Meisel A, Redetzky A, Ruscher K, Trendelenburg G, Victorov I, Riepe M, Diener HC, Dirnagl U (1999) Respiratory chain inhibition induces tolerance to focal cerebral ischemia. J Cereb Blood Flow Metab 19:1229–1237
42. Wright DJ, Renoir T, Smith ZM, Frazier AE, Francis PS, Thorburn DR, McGee SL, Hannan AJ, Gray LJ (2015) N-acetylcysteine improves mitochondrial function and ameliorates behavioral deficits in the R6/1 mouse model of huntington’s disease. Transl Psychiatry 5:e492
43. Zhang M, Li WB, Geng JX, Li QJ, Sun XC, Xian XH, Qi J, Li SQ (2007) The upregulation of glial glutamate transporter-1 participates in the induction of brain ischemic tolerance in rats. J Cereb Blood Flow Metab 27:1352–1368